Clinical Trial Update: A 21 Day Pharmacokinetics Study in Papulopustular Rosacea [Phase 1]

View source ↗

Summary

A 21-day Phase 1 pharmacokinetics study in papulopustular rosacea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Snippet

Sponsor: Maruho Co., Ltd. | Conditions: Papulopustular Rosacea | Phase 1 | Status: COMPLETED